EHAB SARGIOUS: Open Payments
NPI 1619968427 · WARREN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$216 in 12 payments from 8 companies in 2025. Trend: 2023 $645 · 2024 $333 · 2025 $216
Food & beverage: $216
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $58 |
| Teva Pharmaceuticals USA, Inc. | 3 | $53 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| Alkermes, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $16 |
| Lundbeck LLC | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: CAPLYTA, UZEDY, REXULTI, FANAPT, SPRAVATO, ARISTADA, AUSTEDO XR, VRAYLAR.
Industry payments across OH — which companies pay providers there.
